Harris Associates L P Baxter International Inc Transaction History

Harris Associates L P

  • $60.5 Billion
  • Q1 2024

A detailed history of Harris Associates L P transactions in Baxter International Inc stock. As of the latest transaction made, Harris Associates L P holds 9,972,284 shares of BAX stock, worth $331 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
9,972,284
Previous 9,254,946 7.75%
Holding current value
$331 Million
Previous $358 Million 19.12%
% of portfolio
0.7%
Previous 0.62%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$37.88 - $43.77 $27.2 Million - $31.4 Million
717,338 Added 7.75%
9,972,284 $426 Million
Q4 2023

Feb 14, 2024
BUY
$31.71 - $38.95 $49.9 Million - $61.3 Million
1,574,561 Added 20.5%
9,254,946 $358 Million
Q3 2023

Nov 14, 2023
BUY
$37.32 - $49.29 $196 Million - $259 Million
5,254,606 Added 216.62%
7,680,385 $290 Million
Q2 2023

Aug 14, 2023
BUY
$39.98 - $47.68 $96.4 Million - $115 Million
2,410,629 Added 15911.74%
2,425,779 $111 Million
Q1 2023

May 15, 2023
BUY
$37.58 - $52.57 $240,512 - $336,448
6,400 Added 73.14%
15,150 $614,000
Q4 2022

Feb 14, 2023
SELL
$49.7 - $57.71 $15,009 - $17,428
-302 Reduced 3.34%
8,750 $445,000
Q2 2022

Aug 15, 2022
SELL
$63.83 - $80.0 $82,851 - $103,840
-1,298 Reduced 12.54%
9,052 $581,000
Q1 2022

May 16, 2022
SELL
$76.85 - $89.45 $522,579 - $608,260
-6,800 Reduced 39.65%
10,350 $803,000
Q4 2021

Feb 14, 2022
SELL
$74.57 - $87.19 $680,600 - $795,783
-9,127 Reduced 34.73%
17,150 $1.47 Million
Q3 2021

Nov 15, 2021
BUY
$73.77 - $83.61 $51,491 - $58,359
698 Added 2.73%
26,277 $2.11 Million
Q2 2021

Aug 16, 2021
SELL
$80.5 - $88.01 $254,380 - $278,111
-3,160 Reduced 11.0%
25,579 $2.06 Million
Q1 2021

May 17, 2021
BUY
$76.38 - $86.03 $30,552 - $34,412
400 Added 1.41%
28,739 $2.42 Million
Q4 2020

Feb 16, 2021
BUY
$75.39 - $82.36 $36,865 - $40,274
489 Added 1.76%
28,339 $2.27 Million
Q3 2020

Nov 16, 2020
SELL
$78.33 - $90.73 $583,558 - $675,938
-7,450 Reduced 21.1%
27,850 $2.24 Million
Q2 2020

Aug 14, 2020
SELL
$78.66 - $94.14 $5.62 Million - $6.73 Million
-71,495 Reduced 66.95%
35,300 $3.04 Million
Q1 2020

May 15, 2020
SELL
$71.57 - $93.3 $5.78 Million - $7.54 Million
-80,814 Reduced 43.08%
106,795 $8.67 Million
Q4 2019

Feb 14, 2020
SELL
$76.7 - $88.45 $9.37 Million - $10.8 Million
-122,100 Reduced 39.42%
187,609 $15.7 Million
Q3 2019

Nov 14, 2019
SELL
$81.4 - $89.78 $95.6 Million - $105 Million
-1,174,937 Reduced 79.14%
309,709 $27.1 Million
Q2 2019

Aug 14, 2019
SELL
$73.44 - $82.41 $99.8 Million - $112 Million
-1,358,400 Reduced 47.78%
1,484,646 $122 Million
Q1 2019

May 15, 2019
SELL
$64.48 - $81.31 $177 Million - $223 Million
-2,742,018 Reduced 49.1%
2,843,046 $231 Million
Q4 2018

Feb 14, 2019
SELL
$61.45 - $77.8 $75.3 Million - $95.3 Million
-1,225,220 Reduced 17.99%
5,585,064 $368 Million
Q3 2018

Nov 14, 2018
SELL
$70.71 - $77.75 $6.28 Million - $6.9 Million
-88,769 Reduced 1.29%
6,810,284 $525 Million
Q2 2018

Aug 14, 2018
SELL
$63.43 - $75.41 $1.25 Million - $1.49 Million
-19,768 Reduced 0.29%
6,899,053 $509 Million
Q1 2018

May 15, 2018
SELL
$62.56 - $72.26 $128 Million - $148 Million
-2,052,006 Reduced 22.87%
6,918,821 $450 Million
Q4 2017

Feb 14, 2018
SELL
$61.45 - $66.05 $77.4 Million - $83.2 Million
-1,258,941 Reduced 12.31%
8,970,827 $580 Million
Q3 2017

Nov 14, 2017
BUY
$59.5 - $64.61 $609 Million - $661 Million
10,229,768
10,229,768 $642 Million

Others Institutions Holding BAX

# of Institutions
1,025
Shares Held
442M
Call Options Held
4.22M
Put Options Held
2.52M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Harris Associates L P Portfolio

Follow Harris Associates L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harris Associates L P, based on Form 13F filings with the SEC.

News

Stay updated on Harris Associates L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email